Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes

• Published in: BMC cancer 2022-11, Vol.22 (1), p.1-1188, Article 1188
• Main Authors: Sun, Hui, Wang, Xin, Zhang, Xiaoyan, Wang, Xu, Tan, Cong, Weng, Weiwei, Zhang, Meng, Ni, Shujuan, Wang, Lei, Huang, Dan, Xu, Midie, Sheng, Weiqi
• Format: Article
• Language: English
• Subjects: Analysis; Antibodies; Biological markers; Biomarkers; Cancer associated fibroblast; Cancer therapies; Care and treatment; Clinical outcomes; Clinical pathology; Diagnosis; EZH2; FAP; FAP protein; Fibroblasts; Fluorescent antibody technique; FOXM1; Gastric cancer; Gastric mucosa; Gene expression; Genetic aspects; Immunofluorescence; Medical prognosis; Patients; Prognosis; Protein expression; Proteins; Smooth muscle; Stomach cancer; Tumors
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-10312-0

Background The aim of this study is to explore the expression and clinical relevance of CAF-associated markers, EZH2 and FOXM1 in gastric samples. Methods Protein expression were detected and evaluated by multi-plex immunofluorescence (mIF) in 93 cases of gastric cancer (GC) and 31 cases of gastric intraepithelial neoplasia (GIN). The correlation among their expression, and the relationship of them with clinicopathological parameters and prognosis in GC were then analyzed. Results FAP was specific expressed in the CAFs of GC samples, and thus be utilized as a CAF-associated marker in our subsequently analysis. The immunostaining of EZH2, FOXM1 and FAP were significantly upregulated in patients with GC tissues than in those normal gastric mucosa or GIN tissues. The average fluorescence intensity of FAP was slightly positively correlated with EZH2 in GC, GIN and normal samples, whereas the percentage of FAP positive cells has no correlation with that of EZH2. Both the percentage of positive cells and the average fluorescence intensity of FOXM1 were positively correlated with that of FAP and EZH2 in GC, GIN and normal samples, except for FOXM1 and EZH2 expression in normal tissue samples. No significant association was observed between FAP expression and any clinicopathological parameters, whereas the positive frequency of EZH2 and FOXM1 were correlated with tumor location significantly and tumor invasion depth, respectively. In addition, there was strong positive correlations between FAP protein expression and overall survival (OS) and disease-free survival (DFS), and EZH2 expression was positively associated with OS in patients with GC. Furthermore, EZH2 and FAP protein expression was an independent prognostic factor for OS and DFS, respectively. Conclusions These results suggest that both EZH2 and FOXM1 expression was positively associated with CAFs abundance in GC. They may be potential cellular target for therapeutic intervention, especially in patients with a large number of CAFs. Keywords: EZH2, FOXM1, Cancer associated fibroblast, FAP, Prognosis, Gastric cancer, Immunohistochemistry